From Strategy to Execution: The Tools a Board Should Recognize

Strategy tools do not make strategy. They let a board see whether the strategy is sound, whether it is being carried out, and whether the organization stands behind it, provided the board knows what each tool can and cannot show.

In Brief

The Problem. Directors spend more time on strategy than on almost anything else, yet most say execution is where their oversight most needs to improve.

Why It Persists. Boards receive the outputs of strategy tools, such as a strengths, weaknesses, opportunities, and threats (SWOT) grid, a scorecard, or a dashboard, without the assumptions behind them. A familiar format can make an untested strategy look tested.

What Boards Should Do. Recognize the main tools well enough to ask what each one leaves out, and ask management for a short chain that links the strategy's key assumptions to leading measures and to the budget.

Health and life sciences are among the most demanding sectors in which to set strategy. Companies face complex regulation, fast-changing markets, and close scrutiny from patients, clinicians, investors, and regulators. Directors know this, and many still find execution the weakest link. In the National Association of Corporate Directors (NACD) outlook for 2026, more than 60 percent of directors cited strategy execution as the top area for improving oversight, and more than 60 percent of boards are adding strategy discussion to their meetings (National Association of Corporate Directors, 2025).

My argument is that boards do not need more frameworks. Management owns the tools. The board's interest is narrower and more demanding: it should know which tools management uses, what each one can show, and, above all, what each one leaves out. A director who recognizes a tool can read its output critically. A director who does not will tend to accept a familiar format as evidence of rigor.

The Life Cycle of Strategy

I think of strategy as a life cycle with three stages. Formulation sets the long-term goals, assesses strengths and weaknesses, weighs opportunities and threats, and decides where resources go and how success will be measured. Execution carries out the plan: it coordinates resources, aligns activities, and monitors progress. Alignment ensures that the mission, the incentives, the budget, and every department's work point at the same goals, which builds accountability, collaboration, and communication across the organization.

Each stage has tools a director should recognize. Each stage also has a characteristic way of failing, and the tools are only as good as the questions the board asks of them.

Formulation: Testing Where the Organization Competes

A familiar strengths, weaknesses, opportunities, and threats (SWOT) review is a fair starting point. It is rarely sufficient on its own, because it lists factors without weighing them. A director should ask which two or three of those factors the strategy actually depends on.

The Business Model Canvas describes a business on one page in nine building blocks, covering whom the company serves, what it offers, how it delivers, what it costs, and what it earns (Strategyzer, n.d.). Its value to a board is that it makes the revenue model and the cost structure visible together, which matters when a new reimbursement rule or a payer contract changes one of them.

Kim and Mauborgne argue that companies can create uncontested market space instead of fighting for share in crowded markets (Kim and Mauborgne, 2004). The idea is a useful check on a strategy that assumes growth must come at a competitor's expense.

Porter's five forces examine rivalry among existing competitors, the bargaining power of suppliers and of customers, and the threats of new entrants and substitutes (Porter, 2008). In health and life sciences, the power of payers and the threat of substitute therapies often dominate the analysis. Medicare now negotiates prices directly for selected drugs: negotiated prices for the first ten Part D drugs took effect on January 1, 2026, and the Centers for Medicare and Medicaid Services (CMS) estimated that, had they applied in 2023, they would have produced about USD 6 billion in net savings, or 22 percent lower net spending (Centers for Medicare and Medicaid Services, 2024). A five forces review that treats payer power as fixed will miss a change of that size. These four tools can be used together or separately. None of them makes the choice; each shows the board a different side of it.

Execution and Alignment: Turning Intent Into Measures

The balanced scorecard, introduced by Kaplan and Norton in 1992, rests on a plain observation: what you measure is what you get. Financial measures alone can mislead a company about improvement and innovation (Kaplan and Norton, 1992). Their later work on strategy maps showed how an organization can link intangible assets, such as skills and systems, to concrete results (Kaplan and Norton, 2000). For a board, the value of these tools is the chain of cause and effect they make visible. If a strategy depends on faster clinical trial enrollment, the map should show which capabilities produce it and which measures will reveal a shortfall. The board can then ask about the measure before the financial result arrives.

Objectives and key results (OKRs) set a small number of objectives, each with measurable results that show whether it was achieved. Andy Grove developed the method at Intel, and John Doerr introduced it to Google's founders in 1999 (Panchadsaram, n.d.). Used well, OKRs connect each team's work to the organization's priorities and create a culture of accountability.

Three further methods sit closer to operations. Lean Six Sigma streamlines processes and reduces waste and variation. Agile management, which grew from the 2001 Manifesto for Agile Software Development and its preference for "responding to change over following a plan," helps an organization adjust as markets shift (Beck et al., 2001). Design thinking applies designers' methods to services, processes, and strategy to identify what customers need (Brown, 2008). As a Six Sigma Master Black Belt, I value these methods, and I would still not expect a board to review their details. A board should see their results in the measures the strategy depends on.

Where Strategies Fail Quietly

Alignment is where good strategies most often fail without anyone noticing. The board's test is simple. Can management show that incentive plans, capital allocation, and the operating budget point at the same few priorities as the strategy?

Misalignment usually shows up first in the budget. A strategy that names artificial intelligence (AI) as a priority, for example, but funds no data infrastructure, validation, or governance has not yet been adopted. That example is not hypothetical. In the NACD survey, 76 percent of directors say AI will factor into their 2026 growth strategy (National Association of Corporate Directors, 2025). Yet in PwC's 2026 survey of corporate directors, 82 percent rated the information they receive linking AI outcomes, risks, and business performance as fair, poor, or not provided (PwC, 2026). That information is the chain from investment to result that a strategy map is meant to show, and most directors say they do not receive it in usable form.

The Strongest Objection: Tools Are Management's Business

A reasonable director might object that this is exactly the detail a board should avoid. Avancer's own posture is "nose in, fingers out." If management owns the tools, why should directors learn them at all?

The answer is that recognition is not operation. A director who knows that a SWOT review lists factors without weighing them will ask which ones matter. A director who knows that a scorecard is only as good as its leading measures will ask what moves before revenue does. That is nose in. Choosing the tool, running it, and acting on the result remain management's work. That is fingers out.

What the Board Should Receive

A board does not need a catalog of frameworks. It needs a short, stable set of measures linked to the strategy, reported at each meeting, with the assumptions behind the strategy stated plainly. When those assumptions change, management should say so. The board should record what it asked and what it decided.

For the Board

• Which two or three assumptions does our strategy depend on most, and how would we know if one failed?
• Which tools did management use to test the strategy, and what did each one leave out?
• Does our board report link each strategic priority to a leading measure, not only to financial results?
• Do incentive plans, capital allocation, and the operating budget support the same priorities as the strategy?
• Where AI appears in our strategy, what has been funded to support it, and who is accountable?

To discuss how your board oversees strategy and AI together, book a conversation.

References

Beck, K., Beedle, M., van Bennekum, A., Cockburn, A., Cunningham, W., Fowler, M., Grenning, J., Highsmith, J., Hunt, A., Jeffries, R., Kern, J., Marick, B., Martin, R. C., Mellor, S., Schwaber, K., Sutherland, J., and Thomas, D. (2001). Manifesto for Agile Software Development. https://agilemanifesto.org/

Brown, T. (2008). Design thinking. Harvard Business Review, 86(6). https://hbr.org/2008/06/design-thinking

Centers for Medicare and Medicaid Services. (2024, August 15). Medicare Drug Price Negotiation Program: Negotiated prices for initial price applicability year 2026 [Fact sheet]. https://www.cms.gov/newsroom/fact-sheets/medicare-drug-price-negotiation-program-negotiated-prices-initial-price-applicability-year-2026

Kaplan, R. S., and Norton, D. P. (1992). The balanced scorecard: Measures that drive performance. Harvard Business Review, 70(1). https://hbr.org/1992/01/the-balanced-scorecard-measures-that-drive-performance-2

Kaplan, R. S., and Norton, D. P. (2000). Having trouble with your strategy? Then map it. Harvard Business Review, 78(5). https://hbr.org/2000/09/having-trouble-with-your-strategy-then-map-it

Kim, W. C., and Mauborgne, R. (2004). Blue ocean strategy. Harvard Business Review, 82(10). https://hbr.org/2004/10/blue-ocean-strategy

National Association of Corporate Directors. (2025, December 11). Boards prioritize strategic execution, technology and people heading into 2026 [Press release]. https://www.nacdonline.org/about/newsroom/press-release/press-release/boards-prioritize-strategic-execution-technology-people-2026/

Panchadsaram, R. (n.d.). What is an OKR? Definition and examples. What Matters. Retrieved October 21, 2026, from https://www.whatmatters.com/faqs/okr-meaning-definition-example

Porter, M. E. (2008). The five competitive forces that shape strategy. Harvard Business Review, 86(1). https://hbr.org/2008/01/the-five-competitive-forces-that-shape-strategy

PwC. (2026, September 23). Board expertise gaps are rising as oversight demands grow: Insights from PwC's 2026 Annual Corporate Directors Survey [Press release]. https://www.pwc.com/us/en/about-us/newsroom/press-releases/pwc-2026-annual-corporate-directors-survey.html

Strategyzer. (n.d.). Business Model Canvas: Download the official template. Retrieved October 21, 2026, from https://www.strategyzer.com/library/the-business-model-canvas